Pharmigene (ROCO:7595) ROE % Adjusted to Book Value: -12.02% (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7595 Pharmigene Inc ROCO:7595
54 GF Score
Price NT$6.30
GF Value NT$24.76
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Pharmigene ROE % Adjusted to Book Value?

Pharmigene ROCO:7595 -2.33% 54 ROE % Adjusted to Book Value is -12.02% as of Dec. 2025. GuruFocus rates ROCO:7595 with a GF Score™ of 54/100 and a GF Value™ of NT$24.76 (Possible Value Trap). The stock has 7 warning signs investors should review.

Pharmigene's ROE % for the quarter that ended in Dec. 2025 was -21.51%. Pharmigene's PB Ratio for the quarter that ended in Dec. 2025 was 1.79. Pharmigene's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was -12.02%.

Pharmigene ROE % Adjusted to Book Value Related Terms

Pharmigene ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for Pharmigene's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharmigene ROE % Adjusted to Book Value Chart

Pharmigene Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only -2.44 -4.75 -7.89 -10.14 -13.00

Pharmigene Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.70 -10.86 -8.98 -12.79 -12.02

ROCO:7595 vs TMO, DHR, IDXX: ROE % Adjusted to Book Value Comparison

For the Diagnostics & Research subindustry, Pharmigene's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharmigene ROE % Adjusted to Book Value vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Pharmigene's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Pharmigene's ROE % Adjusted to Book Value falls into.


ROCO:7595
54GF Score
Pharmigene Inc ROCO:7595
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pharmigene ROE % Adjusted to Book Value Calculation

Pharmigene's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-23.27% / 1.79
=-13.00%

Pharmigene's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-21.51% / 1.79
=-12.02%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of -12.02% mean?
Pharmigene (ROCO:7595) has a ROE % Adjusted to Book Value of -12.02% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Pharmigene and its competitors.
Is Pharmigene's ROE % Adjusted to Book Value too high?
Pharmigene's current ROE % Adjusted to Book Value is -12.02%. Overall, Pharmigene has a GF Score™ of 54/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Pharmigene's ROE % Adjusted to Book Value compare to TMO and DHR?
Pharmigene's ROE % Adjusted to Book Value of -12.02% can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Medical Diagnostics & Research company?
A good ROE % Adjusted to Book Value depends on the Medical Diagnostics & Research industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Pharmigene and its competitors. Pharmigene's current ROE % Adjusted to Book Value is -12.02%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pharmigene stock overvalued right now?
Based on GuruFocus' analysis, Pharmigene (ROCO:7595) is currently considered Possible Value Trap. The stock's GF Value™ is NT$24.76, compared to a current price of NT$6.30 — trading 74.6% below its estimated fair value. The current ROE % Adjusted to Book Value is -12.02%. Pharmigene's overall GF Score™ is 54/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Pharmigene (ROCO:7595), the current ROE % Adjusted to Book Value is -12.02% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pharmigene (ROCO:7595) Overvalued in 2026?

Based on GuruFocus' analysis, Pharmigene stock appears to be undervalued. The current stock price of NT$6.30 is trading 74.6% below its estimated GF Value™ of NT$24.76. GuruFocus considers Pharmigene to be Possible Value Trap.

Key valuation signals for ROCO:7595:

  • ROE % Adjusted to Book Value: -12.02%
  • GF Value™: NT$24.76 vs. price of NT$6.30 (74.6% below fair value)
  • GF Score™: 54/100 with 7 warning signs

No single metric tells the full story. See the ROCO:7595 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pharmigene Business Description

Address No. 17, Lane 171, Section 2, Jiuzong Road, 4th Floor, Neihu District, Taipei, TWN, 11494
Pharmigene Inc is engaged in the development and sales of pharmaceutical genetic diagnostic products. Also, the company provides medical and drug testing services and equipment.
54GF Score

Get the complete analysis for ROCO:7595

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$6.30
Price
NT$24.76
GF Value